Sonova Holding AG : Good timing based on weekly price data
Entry price | Target | Stop-loss | Potential |
---|
CHF 221.3 |
CHF 241.8 |
CHF 197 |
+9.26% |
---|
Sonova Holding AG shares have returned to important technical levels around 228 CHF based on weekly price data. The timing seems attractive to be a buyer of this stock.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● In a short-term perspective, the company has interesting fundamentals.
Strengths● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at CHF 228 CHF in weekly data.
● The group's high margin levels account for strong profits.
● The group usually releases upbeat results with huge surprise rates.
● For the past twelve months, EPS forecast has been revised upwards.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● The stock is in a well-established, long-term rising trend above the technical support level at 228 CHF
Weaknesses● Based on current prices, the company has particularly high valuation levels.
● The firm trades with high earnings multiples: 24.13 times its 2020 earnings per share.
● The company is not the most generous with respect to shareholders' compensation.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.